Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isodiol International Inc ISOLF

Isodiol International Inc is a manufacturer and developer of phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. It generates revenue from the sale of nutritional health products derived from hemp. Geographically, it derives a majority of revenue from the United States and also has a presence in Canada. Its product categories include Tinctures; Capsules; Topicals; Vape; Oral Spray; Skincare; and others.


GREY:ISOLF - Post by User

Bullboard Posts
Comment by TechnicalDeroon Sep 14, 2018 5:43pm
43 Views
Post# 28624073

RE:THIS IS WHY YOU SHOULDN'T LISTEN TO THE BASHERS!!!

RE:THIS IS WHY YOU SHOULDN'T LISTEN TO THE BASHERS!!!
  • Binding Agreement to Acquire 51% of Farmtiva, a cultivator of hemp with operations in California
  • Binding Agreement to Acquire 51% of Round Mountain Technologies, a cultivator of hemp with operations in Nevada
  • Total Revenue of $9.2 Million with gross profit of $4.6 million
  • Cash Position of $11.5 million
  • Isodiol produces the highest-quality CBD isolate on the market. Isodiol’s CBD extract is derived from top-quality European Certified Organic Hemp. The Company has exclusive contracts with the Academy of Agriculture Science Department, allowing them to test and produce a variety of hemp. Their facilities operate on state-of-the-art equipment, like the highperformance liquid chromatography, resulting in the conversion of their raw extracted oil into a 99%+ pure isolate crystal, which is then used in a variety of their consumer products. The whole process of producing and testing is supervised by an experienced scientific team, ensuring the highest quality and safety of hemp-derived CBD products available on the market.
  • Isodiol expects to increase CBD production by 10x from the current capacity of 2,000 kg/year to 20,000 kg/year. The Company is constructing what it believes to be the world’s largest CBD production facility located in Yunnan, China. Isodiol expects the facility to be up and running by Q1/2019. The initiative to increase production is part of Isodiol’s expansion strategy, as they increase their presence in over-the-counter and pharmaceutical drugs, while pursuing international expansion into Latin America, Asia and Europe.
  • Introduced Isoderm Direct Effects Technology VIA PBS Television (https://isodiol.com/direct-effects-technology/)
  • Signed LOI with Pure Global Cannabis, for supply of pharmaceutical and nutraceutical CBD isolates
  • Partnership between ISO-Sport and ALTIS
  • Expansion of Kure Retail Stores in Arizona, with the opening of seven locations in the Greater Phoenix market
  • Announced the launch of ISOCare,  a secure platform for the cannabis treatment industry
  • Announced plans to develop new hemp-based beers and functional beverages
  • Appointed new Chief Financial Officer, Eli Dusenbury
  • Appointed Marvin Washington to Board of Directors
Bullboard Posts